NEW YORK CENTER FOR LIVER TRANSPLANTATION INC (EIN 133510056) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1988

Legal Domicile

Principal Officer

ELLIOT GRODSTEIN MD

Phone

5185337870

Tax Period

2024-01-01 to 2024-12-31

NEW YORK CENTER FOR LIVER TRANSPLANTATION INC, founded in 1988, is a small nonprofit that reported $678K in total revenue in fiscal year 2024. Expenses of $645K left a modest 5% surplus.

Mission

THE NEW YORK CENTER FOR LIVER TRANSPLANTATION, INC. WAS ESTABLISHED IN 1988 AT THE REQUEST OF THE NEW YORK STATE DEPARTMENT OF HEALTH TO ASSURE THE QUALITY OF CARE DELIVERED TO PATIENTS RECEIVING LIVER TRANSPLANT SERVICES AND TO COORDINATE INFORMATION SHARING AMONG ITS MEMBERS, COLLECT AND REVIEW DATA ON LIVER TRANSPLANT VOLUMES AND OUTCOMES, AND TO SERVE AS A FORUM FOR PROGRAM MONITORING AND PEER REVIEW ACTIVITIES. NYCLT IS A CONSORTIUM OF SEVEN CATEGORY 1 HEALTHCARE INSTITUTIONS THAT OPERATE IN NEW YORK STATE AND FACILITATES A MEANS OF COLLABORATION BETWEEN THE LIVER TRANSPLANT CENTERS WITHIN THE STATE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $276,279

Program Service Revenue $389,069

Investment Income $12,449

Other Revenue $0

TOTAL REVENUE $677,797

Expense Breakdown

Grants Paid $0

Salaries & Benefits $481,083

Fundraising Expenses $0

Program Expenses $616,836

Other Expenses $163,846

TOTAL EXPENSES $644,929

Year-over-Year Comparison

	2024	2023	Change
Revenue	$677,797	$628,889	+0.1%
Expenses	$644,929	$591,941	+0.1%
Net Income	$32,868	$36,948	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$204,264

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROBERTO HERNANDEZ-ALEJANDRO MD	PAST PRESIDENT	0.50	Officer Director	$0	$0	$0
KAREN BERGER	TREASURER	1.00	Officer Director	$0	$0	$0
ELLIOT GRODSTEIN MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
BENJAMIN SAMSTEIN MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
TOMOAKI KATO MD	DIRECTOR	0.50	Director	$0	$0	$0
MILAN KINKHABWALA MD	SECRETARY	0.50	Director	$0	$0	$0
CHIARA ROCHA MD	DIRECTOR	0.50	Director	$0	$0	$0
SARAH BELLEMARE MD	DIRECTOR	0.50	Director	$0	$0	$0
ALYSON FOX MD	DIRECTOR	0.50	Director	$0	$0	$0
NABIL DAGHER MD	DIRECTOR	0.50	Director	$0	$0	$0
KARIM HALAZUN MD	DIRECTOR	0.50	Director	$0	$0	$0
SEIGO NISHIDA MD	DIRECTOR	0.50	Director	$0	$0	$0
THOMAS SCHIANO MD	DIRECTOR	0.50	Director	$0	$0	$0
GOPAL RAMARAJU MD	DIRECTOR	0.50	Director	$0	$0	$0
DANIELLE BRANDMAN MD	DIRECTOR	0.50	Director	$0	$0	$0
NIKOLAOS PYRSOPOULOS MD	DIRECTOR	0.50	Director	$0	$0	$0
SAMANTHA DELAIR	EXECUTIVE DIRECTOR	40.00	Key Emp	$165,303	$38,961	$204,264

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$677,797	$644,929	$612,463	$32,868
2023	$628,889	$591,941	$577,231	$36,948
2022	$560,744	$468,616	$528,196	$92,128
2021	$525,688	$418,687	$455,603	$107,001
2020	$581,358	$505,563	$376,419	$75,795
2019	$564,828	$572,638	$246,873	$-7,810
2018	$736,080	$767,224	$385,725	$-31,144

NEW YORK CENTER FOR LIVER TRANSPLANTATION INC